Treatment‐resistant depression: where to find hope? Daniel Souery World Psychiatry • September 15, 2023 • DOI: 10.1002/wps.21141 (opens in new tab) Copy APA Copy BibTeX Relevant 0 Not relevant 0 Study at a glance AI-extracted from the abstract Characteristics Peer reviewed Topics Depression Citations 2 Abstract convincing phase 3 programme leading to eventual approval of psilocybin as a medicine.We are not there yet. Citations in the library Cited by 1 Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review. Frontiers in Psychiatry 2024